Form 4 Tracker
RxSight, Inc.
RXST

26 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 2, 2026Sep 3 1:45 AMKurtz Ronald M MD
Proposed Sale
5,100$6.96$35.5K—

View →

Sep 2, 2026Sep 3 1:43 AMWilterding Mark
Proposed Sale
7,765$6.96$54.0K—

View →

Sep 2, 2026Sep 3 1:40 AMGoldshleger Ilya
Proposed Sale
2,041$6.96$14.2K—

View →

Sep 2, 2026Sep 3 1:38 AMWeinberg Eric
Proposed Sale
2,041$6.96$14.2K—

View →

Sep 2, 2026Sep 3 1:35 AMRonald M Kurtz MDChief Medical Officer
Sale
5,100$6.96$35.5K71,775(D)

View →

Sep 2, 2026Sep 3 1:35 AMMark WilterdingChief Financial Officer
Sale
7,765$6.96$54.0K25,049(D)

View →

Sep 2, 2026Sep 3 1:34 AMIlya GoldshlegerChief Operating Officer
Sale
2,041$6.96$14.2K81,509(D)

View →

Sep 2, 2026Sep 3 1:33 AMEric WeinbergChief Business Development Officer
Sale
2,041$6.96$14.2K200,348(D)

View →

Aug 18, 2026Aug 18 9:45 PMRAYMOND W COHEN
Proposed Sale
11,890$6.37$75.7K—

View →

Mar 12, 2025Mar 12 8:02 PMTAMARA R FOUNTAIN
Proposed Sale
7,000$25.71$180.0K—

View →

Jan 22, 2025Jan 22 8:56 PMManiar Shweta
Proposed Sale
3,519$30.87$108.6K—

View →

Nov 29, 2024Nov 29 6:29 PMILYA GOLDSHLEGER
Proposed Sale
3,105$46.08$143.1K—

View →

Nov 26, 2024Nov 26 9:13 PMILYA GOLDSHLEGER
Proposed Sale
3,100$45.88$142.2K—

View →

Nov 26, 2024Nov 26 7:45 PMManiar Shweta
Proposed Sale
3,782$45.88$173.5K—

View →

Nov 22, 2024Nov 22 9:15 PMILYA GOLDSHLEGER
Proposed Sale
3,100$45.00$139.5K—

View →

Nov 18, 2024Nov 18 9:29 PMILYA GOLDSHLEGER
Proposed Sale
3,100$45.00$139.5K—

View →

Nov 15, 2024Nov 15 9:18 PMILYA GOLDSHLEGER
Proposed Sale
4,875$46.00$224.3K—

View →

Nov 7, 2024Nov 7 9:14 PMILYA GOLDSHLEGER
Proposed Sale
3,100$55.00$170.5K—

View →

Oct 30, 2024Oct 30 8:28 PMLYA GOLDSHLEGER
Proposed Sale
3,105$51.91$161.2K—

View →

Oct 28, 2024Oct 28 8:15 PMILYA GOLDSHLEGER
Proposed Sale
3,100$50.64$157.0K—

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 27, 2026Mar 4 1:19 AMRonald M Kurtz MDDirector, President & CEO
Grant/Award
80,545—80,545(D)

View →

Jan 12, 2026Jan 30 9:14 PMMark WilterdingChief Financial Officer
Grant/Award
422,298$10.09163,528(D)

View →

← Previous

Page 2 of 2